Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Polish Researchers Cite Rutherrin PDT for Brain Cancer

<< Previous

Bullboard Posts

Next >>

Comment by Vikingstockon Sep 12, 2023 10:16pm

209 Views

Post# 35632964

RE:RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

At the AGM, in my opion he said they are not in a position to do the shelf due to minimum requirements at this time, and started and came back to discuss small pps being the way forward to BTD. The first such pp was announced the next day and now the most recent one. Based on other questions there, control obviously is important as well, impacting available options.

Clearly, after BTD it's a new world, for now more of the same , especially with good results continuing.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement